CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
39.82
-0.03 (-0.09%)
At close: Oct 03, 2025, 3:59 PM
39.50
-0.80%
After-hours: Oct 03, 2025, 07:30 PM EDT
-0.09% (1D)
| Bid | 39.02 |
| Market Cap | 3.04B |
| Revenue (ttm) | 551K |
| Net Income (ttm) | -86.66M |
| EPS (ttm) | -1.87 |
| PE Ratio (ttm) | -21.29 |
| Forward PE | -16.58 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 41 |
| Volume | 548,133 |
| Avg. Volume (20D) | 940,946 |
| Open | 40.16 |
| Previous Close | 39.85 |
| Day's Range | 39.15 - 40.27 |
| 52-Week Range | 14.80 - 40.65 |
| Beta | 1.32 |
| Ex-Dividend Date | n/a |
About CGON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCG Oncology Inc. Common stock is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+6.88%
CG Oncology shares are trading higher after the co...
Unlock content with
Pro Subscription
5 months ago
+4.72%
CG Oncology shares are trading higher after JP Morgan initiated coverage on the stock with an Overweight rating and announced a price target of $41.
